With the spread of modern molecular and cell technologies, biotechnology and pharmaceuticals are currently experiencing a change that is leading to completely new possibilities for advanced therapeutic approaches. Novel cell therapies, for example based on stem cells, require efficient, automated and at the same time adaptive production processes. In addition, there are regulatory requirements that oblige manufacturing companies to implement complex control and quality assurance measures.
The Fraunhofer IPT researches concepts with which manufacturing companies in the biotechnology and pharmaceutical industries can prepare themselves for the challenges of the future: We automate laboratory processes in order to increase throughput and quality and reduce costs. We also network systems and investigate how process data from production facilities can be used to optimize production systems and products.